These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Researchers optimistic about targeted drugs for pancreatic cancer. McBride G J Natl Cancer Inst; 2004 Nov; 96(21):1570-2. PubMed ID: 15523082 [No Abstract] [Full Text] [Related]
17. EGFR as a potential target for the treatment of pancreatic cancer: dilemma and controversies. Nedaeinia R; Avan A; Manian M; Salehi R; Ghayour-Mobarhan M Curr Drug Targets; 2014; 15(14):1293-301. PubMed ID: 25429712 [TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor: a promising therapeutic target for colorectal cancer. Scartozzi M; Pierantoni C; Berardi R; Antognoli S; Bearzi I; Cascinu S Anal Quant Cytol Histol; 2006 Apr; 28(2):61-8. PubMed ID: 16637508 [TBL] [Abstract][Full Text] [Related]
19. The role of epidermal growth factor receptor in prognosis and treatment of gastric cancer. Hong L; Han Y; Brain L Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):111-7. PubMed ID: 24410474 [TBL] [Abstract][Full Text] [Related]
20. Role of novel targeted therapies in the clinic. Herbst RS Br J Cancer; 2005 Jun; 92 Suppl 1(Suppl 1):S21-7. PubMed ID: 15928655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]